Fabricating Genetically Engineered High-Power Lithium-Ion Batteries Using Multiple Virus Genes

Viral Battery In developing materials for batteries, there is a trade-off between charge capacity, conductivity, and chemical stability. Nanostructured materials improve the conductivity for some resistive materials, but fabricating stable materials at nanometer-length scales is difficult. Harnessing their knowledge of viruses as toolkits for materials fabrication, Lee et al. (p. 1051; published online 2 April) modified two genes in the filamentous bacteriophage M13 to produce a virus with an affinity for nucleating amorphous iron phosphate along its length and for attaching carbon nanotubes at one of the ends. In nanostructured form, the amorphous iron phosphate produced a useful cathode material, while the carbon nanotubes formed a percolating network that significantly enhanced conductivity. A genetically modified virus is used to form an efficient cathodic battery material. Development of materials that deliver more energy at high rates is important for high-power applications, including portable electronic devices and hybrid electric vehicles. For lithium-ion (Li+) batteries, reducing material dimensions can boost Li+ ion and electron transfer in nanostructured electrodes. By manipulating two genes, we equipped viruses with peptide groups having affinity for single-walled carbon nanotubes (SWNTs) on one end and peptides capable of nucleating amorphous iron phosphate(a-FePO4) fused to the viral major coat protein. The virus clone with the greatest affinity toward SWNTs enabled power performance of a-FePO4 comparable to that of crystalline lithium iron phosphate (c-LiFePO4) and showed excellent capacity retention upon cycling at 1C. This environmentally benign low-temperature biological scaffold could facilitate fabrication of electrodes from materials previously excluded because of extremely low electronic conductivity.